highperformr logo

Cellares's Overview

Total employees257
HeadquartersSouth San Francisco
Founded2019

Cellares is a pioneering life sciences technology company and an Integrated Development and Manufacturing Organization (IDMO) dedicated to accelerating access to life-saving cell therapies. Cellares focuses on solving the challenges of manual, disconnected, and resource-intensive cell therapy manufacturing processes. Their flagship technology, the Cell Shuttle™, is a fully automated, high-throughput, and closed-platform solution designed to enable scalable, cost-effective, and reliable production of cell therapies from clinical to industrial scale. Cellares aims to make these advanced treatments more accessible to patients worldwide by industrializing manufacturing and offering end-to-end solutions.

Where is Cellares's Headquarters?

HQ Function

Serves as the primary center for corporate leadership, research and development, engineering, and initial manufacturing operations for the Cell Shuttle platform.

Notable Features:

State-of-the-art R&D laboratories, GMP-compliant cleanroom facilities for cell therapy process development and manufacturing, advanced automation and robotics integration areas, and collaborative workspaces designed to foster innovation.

Work Culture:

A dynamic, mission-driven, and innovative environment characteristic of a rapidly growing biotech company. The culture emphasizes collaboration, scientific excellence, agility, and a patient-centric approach to problem-solving in order to advance cell therapy manufacturing.

HQ Significance:

The South San Francisco headquarters is pivotal to Cellares's strategy, housing core innovation teams and advanced infrastructure essential for developing, refining, and scaling its groundbreaking Cell Shuttle technology and IDMO services.

Values Reflected in HQ: The headquarters reflects Cellares's commitment to innovation, quality, scalability, and automation in cell therapy manufacturing, designed to foster cutting-edge research and efficient production.

Location:

Cellares supports cell therapy development and manufacturing globally, with key operational hubs in North America (South San Francisco, CA, and Bridgewater, NJ, USA) and Europe (Stevenage, UK). Their automated Cell Shuttle platform and IDMO services are designed for worldwide deployment, enabling standardized, high-quality manufacturing for clients across different regions. Cellares actively engages with international partners in the pharmaceutical and biotechnology sectors to advance cell therapies worldwide.

Street Address:

1 DNA Way

City:

South San Francisco

State/Province:

CA

Country:

USA

Cellares's Global Presence

Bridgewater, New Jersey, USA

Address: 95 BioNJ Way, Bridgewater, NJ 08807, USA

To serve the East Coast biotech hub and provide large-scale, automated cell therapy manufacturing capabilities, supporting the growing demand from pharmaceutical and biotech partners in North America.

Stevenage, Hertfordshire, UK

Address: Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2FX, UK (Located within the Cell and Gene Therapy Catapult campus)

To provide cell therapy manufacturing solutions and support to European clients, establishing a key operational hub in the UK's prominent cell and gene therapy cluster and facilitating global reach.

Buying Intent Signals for Cellares

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Cellares

As of April 2025, Cellares' leadership includes:

Fabian Gerlinghaus - Co-Founder & Chief Executive Officer
Omar Kurdi - Co-Founder & President
Alex Pesch - Chief Technology Officer
Scott R. Burger, MD - Chief Medical Officer
Mark Flower - Chief Commercial Officer
Scott Ripley - Chief Operating Officer
Windy L. Germany - Chief People Officer
Stephen M. Chang, Ph.D. - Chief Business Officer

Investors of Cellares

Cellares has been backed by several prominent investors over the years, including:

Eclipse Ventures
Decheng Capital
8VC
DFJ Growth
Bristol Myers Squibb
Catalent
Kite, a Gilead Company
Novartis

Executive New Hires/Exits in the Last 12 Months

Hire4
Exits0

Cellares has significantly strengthened its executive team over the past 12-18 months with several key strategic hires in operations, commercial, people, and business leadership to support its rapid growth, global expansion, and scaling of its IDMO Smart Factories.

New Appointments:

Scott Ripley, Scott Ripley appointed as new Chief Operating Officer.
Stephen M. Chang, Ph.D., Dr. Stephen M. Chang appointed as new Chief Business Officer.
Windy L. Germany, Windy L. Germany appointed as new Chief People Officer.
Mark Flower, Mark Flower appointed as new Chief Commercial Officer.

Technology (Tech Stack) used by Cellares

Discover the tools Cellares uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Cellares Email Formats and Examples

Cellares likely utilizes standard corporate email formats. Common patterns for companies of its type include [first_initial][last] or [first].[last] @companydomain.com.

[first_initial][last]@cellares.com (e.g., jdoe@cellares.com) or [first].[last]@cellares.com (e.g., jane.doe@cellares.com)

Format

fgerlinghaus@cellares.com

Example

80%

Success rate

News and media

Cellares / Business WireMarch 12, 2024

Cellares Appoints Scott Ripley as Chief Operating Officer

Cellares announced the appointment of Scott Ripley as Chief Operating Officer. Ripley will oversee Cellares' operations, manufacturing, supply chain, and quality functions as the company scales its commercial-scale IDMO Smart Factories....more

Cellares / Business WireJanuary 9, 2024

Cellares Appoints Dr. Stephen M. Chang as Chief Business Officer

Cellares announced the appointment of Dr. Stephen M. Chang as Chief Business Officer. Dr. Chang brings extensive experience in biopharma business development and will lead Cellares' strategic partnerships and corporate development efforts....more

Cellares / Business WireNovember 14, 2023

Cellares Expands Global Footprint, Acquires State-of-the-Art GMP Cell Therapy Manufacturing Facility in the UK

Cellares announced its expansion into Europe with the acquisition of a state-of-the-art GMP cell therapy manufacturing facility in Stevenage, UK, from the Cell and Gene Therapy Catapult. This facility will serve as Cellares' European Center of Excellence....more

Cellares / Business WireJuly 11, 2023

Cellares Raises $255 Million Series C Financing to Meet Global Demand for its Cell Therapy Manufacturing Platform

Cellares announced the close of a $255 million Series C financing round. The funding will be used to launch its first commercial-scale IDMO Smart Factory, expand its technology differentiation, and meet growing global demand for its automated cell therapy manufacturing solutions....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Cellares, are just a search away.